Loss of BRMS1 promotes a mesenchymal phenotype through NF-κB-Dependent regulation of twist1

Molecular and Cellular Biology

Volumn 35, Issue 1, 2015, Pages 303-317

  Liu, Yuan ^a,c   Mayo, Marty W ^b   Xiao, Aizhen ^b   Hall, Emily H ^b   Amin, Elianna B ^a   Kadota, Kyuichi ^a   Adusumilli, Prasad S ^a,c   Jones, David R ^a,c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER METASTASIS SUPPRESSOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PLASMID DNA; SHORT HAIRPIN RNA; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR TWIST; TRANSCRIPTION FACTOR TWIST1; TRANSFORMING GROWTH FACTOR BETA; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; BRMS1 PROTEIN, HUMAN; HISTONE; NFKB1 PROTEIN, HUMAN; NUCLEAR PROTEIN; REPRESSOR PROTEIN; SMALL INTERFERING RNA; TWIST1 PROTEIN, HUMAN;

ARTICLE; CELL DIFFERENTIATION; CELL INVASION; CELL MIGRATION; CELL VIABILITY; CHROMATIN IMMUNOPRECIPITATION; COLONY FORMATION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; GENE EXPRESSION; GENE ONTOLOGY; HISTONE MODIFICATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MESENCHYME CELL; MICROARRAY ANALYSIS; NON SMALL CELL LUNG CANCER; NONHUMAN; PHENOTYPE; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; WESTERN BLOTTING; ANIMAL; CANCER TRANSPLANTATION; CELL SURVIVAL; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; LYMPH NODE METASTASIS; METABOLISM; METASTASIS; MOUSE; NUDE MOUSE; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE; WOUND HEALING;

ANIMALIA;

ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL SURVIVAL; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HISTONES; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MICE; MICE, NUDE; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NF-KAPPA B P50 SUBUNIT; NUCLEAR PROTEINS; PHENOTYPE; REPRESSOR PROTEINS; RNA, SMALL INTERFERING; TRANSFORMING GROWTH FACTOR BETA; TWIST TRANSCRIPTION FACTOR; WOUND HEALING;

EID: 84920019805     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00869-14     Document Type: Article

References (54)

1. Alamgeer M, Ganju V, Watkins DN. 2013. Novel therapeutic targets in non-small cell lung cancer. Curr Opin Pharmacol 13:394-401. http://dx.doi.org/10.1016/j.coph.2013.03.010.
2. Siegel R, Naishadham D, Jemal A. 2012. Cancer statistics, 2012. CA Cancer J Clin 62:10-29. http://dx.doi.org/10.3322/caac.20138.
3. Connolly EC, Freimuth J, Akhurst RJ. 2012. Complexities of TGF-beta targeted cancer therapy. Int J Biol Sci 8:964-978. http://dx.doi.org/10.7150/ijbs.4564.
4. Moustakas A, Heldin CH. 2009. The regulation of TGFbeta signal transduction. Development 136:3699-3714. http://dx.doi.org/10.1242/dev.030338.
5. Heldin CH, Vanlandewijck M, Moustakas A. 2012. Regulation of EMT by TGFbeta in cancer. FEBS Lett 586:1959-1970. http://dx.doi.org/10.1016/j.febslet.2012.02.037.
6. Zheng H, Kang Y. 2014. Multilayer control of the EMT master regulators. Oncogene 33:1755-1763. http://dx.doi.org/10.1038/onc.2013.128.
7. Fuxe J, Karlsson MC. 2012. TGF-beta-induced epithelial-mesenchymal transition: a link between cancer and inflammation. Semin Cancer Biol 22:455-461. http://dx.doi.org/10.1016/j.semcancer.2012.05.004.
8. Nieto MA. 2011. The ins and outs of the epithelial to mesenchymal transition in health and disease. Annu Rev Cell Dev Biol 27:347-376. http://dx.doi.org/10.1146/annurev-cellbio-092910-154036.
9. Scheel C, Eaton EN, Li SH, Chaffer CL, Reinhardt F, Kah KJ, Bell G, Guo W, Rubin J, Richardson AL, Weinberg RA. 2011. Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell 145:926-940. http://dx.doi.org/10.1016/j.cell.2011.04.029.
10. Wendt MK, Tian M, Schiemann WP. 2012. Deconstructing the mechanisms and consequences of TGF-beta-induced EMT during cancer progression. Cell Tissue Res 347:85-101. http://dx.doi.org/10.1007/s00441-011-1199-1.
11. Xu J, Lamouille S, Derynck R. 2009. TGF-beta-induced epithelial to mesenchymal transition. Cell Res 19:156-172. http://dx.doi.org/10.1038/cr.2009.5.
12. Kumar M, Allison DF, Baranova NN, Wamsley JJ, Katz AJ, Bekiranov S, Jones DR, Mayo MW. 2013. NF-kappaB regulates mesenchymal transition for the induction of non-small cell lung cancer initiating cells. PLoS One 8:e68597. http://dx.doi.org/10.1371/journal.pone.0068597.
13. Chua HL, Bhat-Nakshatri P, Clare SE, Morimiya A, Badve S, Nakshatri H. 2007. NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2. Oncogene 26:711-724. http://dx.doi.org/10.1038/sj.onc.1209808.
14. Julien S, Puig I, Caretti E, Bonaventure J, Nelles L, van Roy F, Dargemont C, de Herreros AG, Bellacosa A, Larue L. 2007. Activation of NF-kappaB by Akt upregulates Snail expression and induces epithelium mesenchyme transition. Oncogene 26:7445-7456. http://dx.doi.org/10.1038/sj.onc.1210546.
15. Pham CG, Bubici C, Zazzeroni F, Knabb JR, Papa S, Kuntzen C, Franzoso G. 2007. Upregulation of Twist-1 by NF-kappaB blocks cytotoxicity induced by chemotherapeutic drugs. Mol Cell Biol 27:3920-3935. http://dx.doi.org/10.1128/MCB.01219-06.
16. Wu Y, Deng J, Rychahou PG, Qiu S, Evers BM, Zhou BP. 2009. Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion. Cancer Cell 15:416-428. http://dx.doi.org/10.1016/j.ccr.2009.03.016.
17. Meehan WJ, Welch DR. 2003. Breast cancer metastasis suppressor 1: update. Clin Exp Metastasis 20:45-50. http://dx.doi.org/10.1023/A:1022542519586.
18. Smith PW, Liu Y, Siefert SA, Moskaluk CA, Petroni GR, Jones DR. Breast cancer metastasis suppressor 1 (BRMS1) suppresses metastasis and correlates with improved patient survival in non-small cell lung cancer. Cancer Lett 276:196-203. http://dx.doi.org/10.1016/j.canlet.2008.11.024.
19. Liu Y, Mayo MW, Nagji AS, Smith PW, Ramsey CS, Li D, Jones DR. 2012. Phosphorylation of RelA/p65 promotes DNMT-1 recruitment to chromatin and represses transcription of the tumor metastasis suppressor gene BRMS1. Oncogene 31:1143-1154. http://dx.doi.org/10.1038/onc.2011.308.
20. Nagji AS, Liu Y, Stelow EB, Stukenborg GJ, Jones DR. 2010. BRMS1 transcriptional repression correlates with CpG island methylation and advanced pathological stage in non-small cell lung cancer. J Pathol 221: 229-237. http://dx.doi.org/10.1002/path.2707.
21. Seraj MJ, Samant RS, Verderame MF, Welch DR. 2000. Functional evidence for a novel human breast carcinoma metastasis suppressor, BRMS1, encoded at chromosome 11q13. Cancer Res 60:2764-2769.
22. Shevde LA, Samant RS, Goldberg SF, Sikaneta T, Alessandrini A, Donahue HJ, Mauger DT, Welch DR. 2002. Suppression of human melanoma metastasis by the metastasis suppressor gene, BRMS1. Exp Cell Res 273:229-239. http://dx.doi.org/10.1006/excr.2001.5452.
23. Wu J, Wang Y, Qiao X, Saiyin H, Zhao S, Qiao S, Wu Y. 2013. Cloning and characterization of a novelhumanBRMS1transcript variant in hepatocellular carcinoma cells. Cancer Lett 337:266-275. http://dx.doi.org/10.1016/j.canlet.2013.04.030.
24. Zhang S, Lin QD, Di W. 2006. Suppression of human ovarian carcinoma metastasis by the metastasis-suppressor gene, BRMS1. Int J Gynecol Cancer 16:522-531. http://dx.doi.org/10.1111/j.1525-1438.2006.00547.x.
25. Liu Y, Smith PW, Jones DR. 2006. Breast cancer metastasis suppressor 1 functions as a corepressor by enhancing histone deacetylase 1-mediated deacetylation of RelA/p65 and promoting apoptosis. Mol Cell Biol 26: 8683-8696. http://dx.doi.org/10.1128/MCB.00940-06.
26. DeWald DB, Torabinejad J, Samant RS, Johnston D, Erin N, Shope JC, Xie Y, Welch DR. 2005. Metastasis suppression by breast cancer metastasis suppressor 1 involves reduction of phosphoinositide signaling in MDA-MB-435 breast carcinoma cells. Cancer Res 65:713-717.
27. Edmonds MD, Hurst DR, Welch DR. 2009. Linking metastasis suppression with metastamiR regulation. Cell Cycle 8:2673-2675. http://dx.doi.org/10.4161/cc.8.17.9303.
28. Li J, Cheng Y, Tai D, Martinka M, Welch DR, Li G. 2011. Prognostic significance of BRMS1 expression in human melanoma and its role in tumor angiogenesis. Oncogene 30:896-906. http://dx.doi.org/10.1038/onc.2010.470.
29. Liu Y, Mayo MW, Nagji AS, Hall EH, Shock LS, Xiao A, Stelow EB, Jones DR. 2013. BRMS1 suppresses lung cancer metastases through an E3 ligase function on histone acetyltransferase p300. Cancer Res 73:1308-1317. http://dx.doi.org/10.1158/0008-5472.CAN-12-2489.
30. Nitsche A, Becker M, Junghahn I, Aumann J, Landt O, Fichtner I, Wittig B, Siegert W. 2001. Quantification of human cells in NOD/SCID mice by duplex real-time polymerase-chain reaction. Haematologica 86: 693-699.
31. Nishiya N, Kiosses WB, Han J, Ginsberg MH. 2005. An alpha4 integrinpaxillin- Arf-GAP complex restricts Rac activation to the leading edge of migrating cells. Nat Cell Biol 7:343-352. http://dx.doi.org/10.1038/ncb1234.
32. Groger CJ, Grubinger M, Waldhor T, Vierlinger K, Mikulits W. 2012. Meta-analysis of gene expression signatures defining the epithelial to mesenchymal transition during cancer progression. PLoS One 7:e51136. http://dx.doi.org/10.1371/journal.pone.0051136.
33. Thiery JP, Sleeman JP. 2006. Complex networks orchestrate epithelialmesenchymal transitions. Nat Rev Mol Cell Biol 7:131-142. http://dx.doi.org/10.1038/nrm1835.
34. Hall EH, Liu Y, Xiao A, Shock L, Brautigan DL, Mayo MW, Adusumilli PS, Jones DR. 2014. Inhibition of breast cancer metastasis suppressor 1 promotes a mesenchymal phenotype in lung epithelial cells that express oncogenic K-RasV12 and loss of p53. PLoS One 9:e95869. http://dx.doi.org/10.1371/journal.pone.0095869.
35. Ventura A, Meissner A, Dillon CP, McManus M, Sharp PA, Van Parijs L, Jaenisch R, Jacks T. 2004. Cre-lox-regulated conditional RNA interference from transgenes. Proc Natl Acad SciUSA101:10380-10385. http://dx.doi.org/10.1073/pnas.0403954101.
36. Bolstad BM, Irizarry RA, Astrand M, Speed TP. 2003. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19:185-193. http://dx.doi.org/10.1093/bioinformatics/19.2.185.
37. Liu Y, Denlinger CE, Rundall BK, Smith PW, Jones DR. 2006. Suberoylanilide hydroxamic acid induces Akt-mediated phosphorylation of p300, which promotes acetylation and transcriptional activation of RelA/p65. J Biol Chem 281:31359-31368. http://dx.doi.org/10.1074/jbc. M604478200.
38. Li CW, Xia W, Huo L, Lim SO, Wu Y, Hsu JL, Chao CH, Yamaguchi H, Yang NK, Ding Q, Wang Y, Lai YJ, LaBaffAM, Wu TJ, Lin BR, Yang MH, Hortobagyi GN, Hung MC. 2012. Epithelial-mesenchymal transition induced by TNF-alpha requires NF-kappaB-mediated transcriptional upregulation of Twist1. Cancer Res 72:1290-1300. http://dx.doi.org/10.1158/0008-5472.CAN-11-3123.
39. Yue PY, Leung EP, Mak NK, Wong RN. 2010. A simplified method for quantifying cell migration/wound healing in 96-well plates. J Biomol Screen 15:427-433. http://dx.doi.org/10.1177/1087057110361772.
40. Humphries MJ. 2009. Cell adhesion assays. Methods Mol Biol 522:203-210. http://dx.doi.org/10.1007/978-1-59745-413-1_14.
41. Roberts AB, Tian F, Byfield SD, Stuelten C, Ooshima A, Saika S, Flanders KC. 2006. Smad3 is key to TGF-beta-mediated epithelial-tomesenchymal transition, fibrosis, tumor suppression and metastasis. Cytokine Growth Factor Rev 17:19-27. http://dx.doi.org/10.1016/j.cytogfr.2005.09.008.
42. Deckers M, van Dinther M, Buijs J, Que I, Lowik C, van der Pluijm G, ten Dijke P. 2006. The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells. Cancer Res 66:2202-2209. http://dx.doi.org/10.1158/0008-5472.CAN-05-3560.
43. Jones DR, Broad RM, Madrid LV, Baldwin AS, Jr, Mayo MW. 2000. Inhibition of NF-kappaB sensitizes non-small cell lung cancer cells to chemotherapy-induced apoptosis. Ann Thorac Surg 70:930-937. http://dx.doi.org/10.1016/S0003-4975(00)01635-0.
44. Dahmus ME. 1996. Phosphorylation of mammalian RNA polymerase II. Methods Enzymol 273:185-193. http://dx.doi.org/10.1016/S0076-6879(96)73019-7.
45. Tsai JH, Donaher JL, Murphy DA, Chau S, Yang J. 2012. Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell 22:725-736. http://dx.doi.org/10.1016/j.ccr.2012.09.022.
46. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A, Weinberg RA. 2004. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117:927-939. http://dx.doi.org/10.1016/j.cell.2004.06.006.
47. Elkin M, Vlodavsky I. 2001. Tail vein assay of cancer metastasis. Curr Protoc Cell Biol Chapter 19:Unit 19.12. http://dx.doi.org/10.1002/0471143030.cb1902s12.
48. Cicek M, Fukuyama R, Welch DR, Sizemore N, Casey G. 2005. Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-kappaB activity. Cancer Res 65:3586-3595. http://dx.doi.org/10.1158/0008-5472.CAN-04-3139.
49. Basseres DS, Baldwin AS. 2006. Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression. Oncogene 25:6817-6830. http://dx.doi.org/10.1038/sj.onc.1209942.
50. Huber MA, Azoitei N, Baumann B, Grunert S, Sommer A, Pehamberger H, Kraut N, Beug H, Wirth T. 2004. NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J Clin Invest 114:569-581. http://dx.doi.org/10.1172/JCI200421358.
51. Tobar N, Villar V, Santibanez JF. 2010. ROS-NFkappaB mediates TGFbeta1-induced expression of urokinase-type plasminogen activator, matrix metalloproteinase-9 and cell invasion. Mol Cell Biochem 340:195-202. http://dx.doi.org/10.1007/s11010-010-0418-5.
52. Wu K, Bonavida B. 2009. The activated NF-kappaB-Snail-RKIP circuitry in cancer regulates both the metastatic cascade and resistance to apoptosis by cytotoxic drugs. Crit Rev Immunol 29:241-254. http://dx.doi.org/10.1615/CritRevImmunol.v29.i3.40.
53. Pantuck AJ, An J, Liu H, Rettig MB. 2010. NF-kappaB-dependent plasticity of the epithelial to mesenchymal transition induced by Von Hippel- Lindau inactivation in renal cell carcinomas. Cancer Res 70:752-761. http://dx.doi.org/10.1158/0008-5472.CAN-09-2211.
54. Pause A, Peterson B, Schaffar G, Stearman R, Klausner RD. 1999. Studying interactions of four proteins in the yeast two-hybrid system: structural resemblance of the pVHL/elongin BC/hCUL-2 complex with the ubiquitin ligase complex SKP1/cullin/F-box protein. Proc Natl Acad Sci U S A 96:9533-9538. http://dx.doi.org/10.1073/pnas.96.17.9533.